The effect of curcumin on postpartum depression and anxiety in primiparous women.. Mild mental and behavioural disorders associated with the puerperium, not elsewhere classified Depression
Conditions
Interventions
Intervention 1: Intervention group: Curcumin (500 mg) capsules will be prepared by the pharmacist colleague will be taken daily from the seventh day after delivery with a glass of water, two hours af
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Women aged 18 to 40 Living in Tabriz city and suburbs Not having a chronic disease such as liver or kidney disease Not having a history of depression or any other mental disorders No alcohol and drugs abuse Primiparous women who have given birth in the last 12 hours Natural delivery or caesarean section Recent low-risk pregnancy Willingness to participate in the study Having a health record at the nearest health center of residence Having a home phone number or a mobile phone number (both the participant and her spouse) No change of location during the study period Not taking medications that cause depression symptoms
Exclusion criteria
Exclusion criteria: Diagnosis of prenatal depression Death or hospitalization of the infant in the intensive care unit Hospitalization of the mother due to postpartum complications People who will experience tragic events after giving birth, such as the death or hospitalization of a family member, or divorce Taking anticoagulants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The post partum depression in the groups who will scored less than 12 on Edinburg Postnatal Depression Scale before assigned to groups. Timepoint: Before and after taking Curcumin capsule (500 mg) daily in interventional group and Placebo capsule (500 mg) daily in placebo group from the seventh day after delivery, until 8 weeks. Method of measurement: Edinburgh Postnatal Depression Scale.;The level of post partum anxiety in the intervention and control groups. Timepoint: Before and after taking Curcumin capsule (500 mg) daily in interventional group and Placebo capsule (500 mg) daily in placebo group from the seventh day after delivery, until 8 weeks. Method of measurement: Postpartum specific anxiety scale research short-form (psas-rsf). | — |
Secondary
| Measure | Time frame |
|---|---|
| The satisfaction with the use of curcumin and placebo in the intervention and control groups. Timepoint: After ending the study. Method of measurement: Questionnaire related to patient satisfaction.;The side effects of using curcumin or placebo in the intervention and control groups. Timepoint: After ending the study. Method of measurement: Questionnaire related to side effects.;Breast milk sufficiency will be determined by infant's weighting. If weight gain be 110-200 gram weekly, breast milk will be considered sufficient. Timepoint: Birth weight, infant's weightings which will be down in health center and weighting at the end of study will be recorded in infant's weight checklist. Method of measurement: Infant weight checklist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahin Kamalifard
Tabriz University of Medical Sciences
Outcome results
None listed